BenQ Medical Technology (4116.TWO) Earnings Analysis
BenQ Medical Technology (4116.TWO) has no confirmed upcoming earnings date. Trailing P/E 25.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4116.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4116.TWO. This page updates as the calendar is published.
4116.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-03-31 | 0.5 TWD | n/a | n/a | n/a |
| 2024-12-31 | 0.592 TWD | n/a | n/a | n/a |
| 2024-09-29 | 0.6 TWD | n/a | n/a | n/a |
4116.TWO valuation and analyst view
| Trailing P/E | 25.36 |
|---|---|
| Trailing EPS | 0.38414 TWD |
| Price / book | 6.60 |
| Dividend yield | 5.15% |
| Market cap | 1.72B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is BenQ Medical Technology (4116.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4116.TWO. This page updates as the calendar is published.
Did 4116.TWO beat earnings last quarter?
Consensus estimate data was not available for 4116.TWO's 2025-03-31 report.
What is 4116.TWO's current P/E ratio and EPS?
4116.TWO trades at a trailing P/E of 25.36 on trailing EPS of 0.3841362825303841 TWD.
What do analysts rate 4116.TWO?
4116.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.